Researchers Discover Red Light Therapy Reduces Blood Glucose Levels

A recent study published in the Journal of Biophotonics has demonstrated that light stimulation of mitochondria could significantly reduce blood glucose spikes following meals. This ground-breaking research offers new insights into how we might mitigate some of the harmful fluctuations of blood sugar in the body.

Led by Michael B. Powner and Glen Jeffery from the Department of Optometry and Visual Science at City, University of London, and the Department of Visual Neuroscience at UCL Institute of Ophthalmology respectively, the study investigates the effects of photobiomodulation (PBM) with red light on human blood glucose levels.

Photobiomodulation, specifically with a wavelength of 670 nm, has been known to increase mitochondrial functions, such as enhancing membrane potentials and boosting adenosine triphosphate (ATP) production. ATP is a molecule that carries energy within cells and is crucial for various bodily functions. The current findings suggest that PBM can amplify glucose demand, which could, in turn, influence blood sugar levels.

In their experiment, the researchers subjected thirty healthy participants to an oral glucose tolerance test (OGTT). The test showed that a 15-minute exposure to 670 nm light significantly decreased the blood glucose elevation after glucose intake by approximately 27.7% over two hours. Moreover, the exposure reduced the maximum glucose spiking by 7.5%. This finding implies that using PBM with red light could be a potential strategy to lower blood glucose spikes post-meals, which often pose a health risk.

The researchers note the broader impacts of their discovery, especially given that the variability in glucose regulation could lead to serious health consequences, including inflammation and insulin resistance. By providing a technique to reduce blood glucose levels and spikes, this research could help in developing new treatments to maintain blood glucose homeostasis and prevent complications in conditions such as diabetes.

The study utilized a control group for comparison and employed rigorous statistical analyses to validate the results. While the study was conducted on a healthy cohort, its implications for diabetic patients warrant further investigation.

This scientific advance not only opens new avenues for diabetes management but also underscores the importance of exploring the therapeutic potential of light. As the study's details gain traction, further research may catalyze new health technologies and treatment strategies that could benefit millions of individuals worldwide.

The full research article can be accessed at the Wiley Online Library: DOI: 10.1002/jbio.202300521. The study was supported by Sight Research UK and is an excellent example of the innovative endeavors within the field of biophotonics.

For a comprehensive understanding of this pioneering study, you're invited to review the original work properly cited under the Creative Commons Attribution License and accessible via the link provided. The article's reported findings are a valuable contribution to health science, paving the way for future advancements in medical treatments and technologies.

Built with the help of Buoy Health.